Latest Microbicide Stories
The National Science Foundation awards a $150,000 Phase I SBIR Grant to Agile Sciences Raleigh, NC (PRWEB) July 09, 2012 Agile Sciences has been awarded
Today IRMA (International Rectal Microbicide Advocates) will release "On the Map: Ensuring Africa's Place in Rectal Microbicide Research and Advocacy" at a special evening reception at the international Microbicides 2012 conference at the Sydney Convention and Exhibition Center.
Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom.
BETHLEHEM, Pa., Jan. 26 /PRNewswire/ -- Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.
New research in the FASEB Journal describes a one-two punch in the battle against HIV.
LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.
FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV.
Gels that have been developed to protect women from the AIDS virus may be just as likely to protect men from catching the disease as well, researchers said on Monday.
Experiments in female monkeys have for the first time shown that when used in combination, vaginal gels known as microbicides can protect against an HIV-like virus. The research, funded largely by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), suggests that similar combination microbicides could potentially provide a safe, effective and practical way to prevent HIV transmission to women, according to study investigators.
Research with female monkeys at the Tulane National Primate Research Center has for the first time shown that three different anti-viral agents in a vaginal gel protect the animals against an HIV-like virus. The research suggests that a microbicide using compounds that inhibit the processes by which HIV attaches to and enters target cells could potentially provide a safe, effective and practical way to prevent HIV transmission in women, according to study investigators. The study, published...